Stock DNA
Specialty Chemicals
MXN 21,973 Million (Small Cap)
NA (Loss Making)
NA
0.00%
1.18
-8.79%
0.84
Revenue and Profits:
Net Sales:
32,789 Million
(Quarterly Results - Jun 2025)
Net Profit:
-521 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.06%
0%
-18.06%
6 Months
-30.39%
0%
-30.39%
1 Year
-28.66%
0%
-28.66%
2 Years
-47.11%
0%
-47.11%
3 Years
-63.62%
0%
-63.62%
4 Years
-58.27%
0%
-58.27%
5 Years
-40.94%
0%
-40.94%
Alpek SAB de CV for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.54%
EBIT Growth (5y)
-10.89%
EBIT to Interest (avg)
3.88
Debt to EBITDA (avg)
2.11
Net Debt to Equity (avg)
1.22
Sales to Capital Employed (avg)
2.07
Tax Ratio
90.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
17.32%
ROE (avg)
14.36%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.77
EV to EBIT
11.58
EV to EBITDA
5.47
EV to Capital Employed
0.89
EV to Sales
0.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.72%
ROE (Latest)
-3.39%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot : Mar 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
32,788.70
35,022.30
-6.38%
Operating Profit (PBDIT) excl Other Income
1,851.10
2,533.30
-26.93%
Interest
841.90
1,006.00
-16.31%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-521.50
406.10
-228.42%
Operating Profit Margin (Excl OI)
16.60%
35.00%
-1.84%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -6.38% vs 0.46% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -228.42% vs 126.91% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
137,409.00
138,159.00
-0.54%
Operating Profit (PBDIT) excl Other Income
10,446.00
9,065.00
15.23%
Interest
4,370.00
3,936.00
11.03%
Exceptional Items
-1,791.00
-11,078.00
83.83%
Consolidate Net Profit
-212.00
-10,033.00
97.89%
Operating Profit Margin (Excl OI)
41.30%
32.20%
0.91%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -0.54% vs -34.96% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 97.89% vs -162.84% in Dec 2023
About Alpek SAB de CV 
Alpek SAB de CV
Specialty Chemicals
Alpek SAB de CV is a Mexico-based company engaged in the chemicals sector. The Company's activities are divided into two business segments: Polyester and Plastics & Chemicals. The Polyester division focuses on the manufacture and distribution of purified terephthalic acid (PTA), polyethylene terephthalate (PET) and polyester fiber. The Plastics & Chemicals division is responsible for the production of polypropylene (PP), expandable polystyrene (EPS), caprolactam (CPL), ammonium sulfate, as well as specialty and industrial chemicals, such as surfactants, ethoxilates, glycoethers and desemulsionates. The Company's products are used in a range of industries, including consumer goods, food and beverages, automotive, construction, agriculture, oil and gas, as well as pharmaceuticals. It operates a number of production plants in the Americas. The Company is controlled by Alfa SAB de CV.
Company Coordinates 
Company Details
AVE. GOMEZ MORIN NO. 1111-C SUR, CARRIZALEJO SAN PEDRO GARZA GARCIA None : 66254
Registrar Details






